MASLD Pharmacotherapy – Current Standards, Emerging Treatments, and Practical Guidance for Indian Physicians (2025) Ashish Kumar

Description

This review provides a comprehensive overview of current and evolving pharmacologic options for Metabolic dysfunction-associated steatotic liver disease (MASLD). It analyzes key mechanisms and novel therapies, including resmetirom and GLP-1RAs. The text focuses on providing practical recommendations and a structured treatment algorithm tailored specifically for Indian physicians, considering resource constraints and therapeutic availability in the region.